Loading
A phase 2/3 trial of adebrelimab, SHR-8068, pemetrexed, carboplatin and other drugs in lung cancer, run by Shanghai Shengdi Pharmaceutical Co., Ltd, not yet recruiting.
A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients is a phase 2/3, randomised interventional study registered as NCT06335355 by Shanghai Shengdi Pharmaceutical Co., Ltd, with a registry enrolment figure of 401 participants, started 2024-03 and due to reach its primary completion in 2028-10. Interventions recorded: Adebrelimab + SHR-8068 + Pemetrexed + Carboplatin; Camrelizumab + Pemetrexed + Carboplatin; Adebrelimab + Pemetrexed + Carboplatin. Conditions listed: Non-squamous Non-small Cell Lung Cancer. Primary outcome: Investigator-assessed Objective Response Rate (Phase One); Overall Survival (Phase Two). Lung eligibility wording from the registry: "Diagnosed with advanced or metastatic non-squamous NSCLC (non-small cell lung cancer) confirmed by histology or cytology". Sites: China. No results are recorded here; the registry entry is the source.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Adebrelimab, Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin, Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin, Cytotoxic chemotherapy and the tag lung-deep-dive.